Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥974m2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥3.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income−¥547m2025-04-01 → 2025-09-30Cons.Operating income
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income−¥483m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥45m2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax−¥483m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)−¥486m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥103m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income−¥486m2025-04-01 → 2025-09-30Cons.Profit loss
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥9.4bnat 2025-09-30Cons.Assets
Total assets¥9.7bnat 2025-03-31Cons.Assets
Total assets¥9.4bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥688mat 2025-09-30Cons.Liabilities
Total liabilities¥686mat 2025-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥9.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥2.8bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥2.6bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥342m2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥123m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥796m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-5.142025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.112024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio92.9%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2025-04-01 → 2025-09-30−¥341m
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥119m
Research Support Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥23m
—segment totalrevenue2025-04-01 → 2025-09-30¥974m
—segment totalrevenue external2025-04-01 → 2025-09-30¥974m
—segment totalsegment ordinary income2025-04-01 → 2025-09-30−¥142m
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 470
ItemContextValueUnit
Income before income taxesPrior1InterimDuration-103257000JPY
Income before income taxesInterimDuration-483389000JPY
Amortization of goodwill ope cfPrior1InterimDuration1356000JPY
Amortization of goodwill ope cfInterimDuration1356000JPY
Depreciation and amortization ope cfPrior1InterimDuration20406000JPY
Depreciation and amortization ope cfInterimDuration33016000JPY
Share based compensation expenses ope cfPrior1InterimDuration25187000JPY
Share based compensation expenses ope cfInterimDuration24858000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1InterimDuration-6768000JPY
Increase decrease in allowance for doubtful accounts ope cfInterimDuration-3791000JPY
Increase decrease in provision for bonuses ope cfPrior1InterimDuration4159000JPY
Increase decrease in provision for bonuses ope cfInterimDuration-1728000JPY
Interest income ope cfPrior1InterimDuration-31160000JPY
Interest income ope cfInterimDuration-41493000JPY
Subsidy income ope cfPrior1InterimDuration-14611000JPY
Subsidy income ope cfInterimDuration-JPY
Equity in earnings losses of affiliates ope cfPrior1InterimDuration3735000JPY
Equity in earnings losses of affiliates ope cfInterimDuration23470000JPY
Foreign exchange losses gains ope cfPrior1InterimDuration22707000JPY
Foreign exchange losses gains ope cfInterimDuration-28162000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration47034000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration134634000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-35966000JPY
Decrease increase in inventories ope cfInterimDuration-32935000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration-47523000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration16143000JPY
Increase decrease in accounts payable other ope cfPrior1InterimDuration-7829000JPY
Increase decrease in accounts payable other ope cfInterimDuration-26301000JPY
Increase decrease in other current liabilities ope cfPrior1InterimDuration8716000JPY
Increase decrease in other current liabilities ope cfInterimDuration-16629000JPY
Other net ope cfPrior1InterimDuration-81199000JPY
Other net ope cfInterimDuration-8495000JPY
Subtotal ope cfPrior1InterimDuration-195013000JPY
Subtotal ope cfInterimDuration-409446000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration31160000JPY
Interest and dividends income received ope cf inv cfInterimDuration41166000JPY
Proceeds from subsidy ope cfPrior1InterimDuration34609000JPY
Proceeds from subsidy ope cfInterimDuration29950000JPY
Income taxes paid ope cfPrior1InterimDuration-1913000JPY
Income taxes paid ope cfInterimDuration-3913000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration-131156000JPY
Net cash provided by used in operating activitiesInterimDuration-342243000JPY
Proceeds from redemption of securities inv cfPrior1InterimDuration1600000000JPY
Proceeds from redemption of securities inv cfInterimDuration100000000JPY
Purchase of investment securities inv cfPrior1InterimDuration-2000450000JPY
Purchase of investment securities inv cfInterimDuration-JPY
Proceeds from redemption of investment securities inv cfPrior1InterimDuration-JPY
Proceeds from redemption of investment securities inv cfInterimDuration56162000JPY
Purchase of property plant and equipment inv cfPrior1InterimDuration-11995000JPY
Purchase of property plant and equipment inv cfInterimDuration-33515000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass